glp 1 drugs how they work GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Glucagon-like peptide-1 receptor agonists

glp 1 drugs how they work GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Glucagon-like peptide-1 receptor agonists

Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study | The BMJ

Fiber undergoes bacterial fermentation in the colon, producing short-chain fatty acids (SCFAs)—particularly butyrate, propionate, and acetate—which can stimulate L-cell GLP-1 secretion

Pharmaceutical GLP-1 agonists—such as semaglutide—have become popular, but they are synthetic, require prescriptions, and may carry side effects with long-term use